Oncology

  1. Rozlytrek (entrectinib)
    Rozlytrek (entrectinib)
    by Genentech, Inc
    for Solid Tumor
    €9,278.00
  2. Balversa (erdafitinib)
    Balversa (erdafitinib)
    by Janssen Pharmaceutica
    for Urothelial Carcinoma
    €75,340.00
  3. Calquence (acalabrutinib)
    Calquence (acalabrutinib)
    by AstraZeneca Pharmaceuticals LP
    for Lymphoma
    €20,676.00
  4. Libtayo (cemiplimab-rwlc)
    Libtayo (cemiplimab-rwlc)
    by
    for Skin Cancer
    €17,380.00
  5. Lorbrena/Lorviqua (lorlatinib)
    Lorbrena/Lorviqua (lorlatinib)
    by Pfizer Limited
    for Lung Cancer
    €10,885.55
  6. Vitrakvi (larotrectinib)
    Vitrakvi (larotrectinib)
    by Bayer
    for Solid Tumor
    €14,800.00
  7. Vizimpro (dacomitinib)
    Vizimpro (dacomitinib)
    by Pfizer Limited
    for Lung Cancer
    €19,680.00
  8. Copiktra (duvelisib)
    Copiktra (duvelisib)
    by Verastem Inc.
    for Leukemia, Lymphoma
    €16,800.00
  9. Erleada (apalutamide)
    Erleada (apalutamide)
    by Janssen Biotech
    for Prostate Cancer
    €4,225.86
View as Grid List

Items 1-9 of 42

Page
per page
Set Descending Direction